Position in TRVI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$596
-$418 QoQ
Shares Held
32
-62.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#204
of 216 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. TRVI ranks #194 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in TRVI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $596 | 32 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,014 | 85 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $50 | 4 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $36 | 4 | Shares | Defined | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||